Fifth Eye | Top Artificial Intelligence Solutions Company 2022
Healthcare Tech Outlook
>> >>

Fifth Eye
Intelligent Patient Monitoring using Predictive Analytics

Intelligent Patient Monitoring using Predictive Analytics

Follow Fifth Eye on :

Jennifer Baird, Fifth Eye  | Healthcare Tech Outlook | Top Artificial Intelligence Solutions CompaniesJennifer Baird, CEO, Fifth Eye
Healthcare organizations are searching for ways to reduce nursing workload and cognitive burden while simultaneously improving surveillance to accelerate awareness of emerging health problems in patients. The goal is to enable clinicians to make timely diagnoses and interventions that avoid crises. Additionally, hospitals are also seeking indicators to help confirm when patients are ready to be moved from intensive to lower levels of care in a safe and timely fashion. Michigan-based Fifth Eye Inc. is making this a reality with its artificial intelligence-based patient health monitoring system that can detect and predict hemodynamic instability. The AI solutions provider began its journey in 2014 when the Michigan emergency medicine department was exploring ways to improve healthcare and exhibited promising results on the research front. This resulted in the inception of Fifth Eye Inc. — a company that developed easily deployable medical device software and was awarded an FDA De Novo grant in March 2021 for its first-generation product, the Analytic for Hemodynamic Instability (AHI). Fifth Eye followed rapidly with its second-generation product, the AHI System™, which was FDA cleared in December 2021. The AHI System incorporated the company’s second analytic, the AHI Predictive Indicator (AHI-PI).

Unlike other existing solutions that solely depend on vital signs or EHR records to analyze patterns in the patient’s health, Fifth Eye’s AHI System automatically collects data and updates the hemodynamic status of patients every two minutes. “At Fifth Eye, our technology has enabled the application of hemodynamic instability as a new vital sign. We’re empowering clinicians with new information leading to proactive patient re-evaluation rather than costly crisis care,” explains Jennifer Baird, CEO, Fifth Eye Inc. The AHI System provides clinicians with continuously updated, easy-to-interpret information including trends of patients’ hemodynamic status and predictions of the risk of future episodes of hemodynamic instability. Importantly, the AHI System predicted 89% of first episodes of hemodynamic instability with a median lead-time of 48 minutes ahead of continuously monitored vital signs. This early awareness of emerging problems can provide clinicians with the time that they need to diagnose and intervene, potentially avoiding an adverse event.

AHI works on the underlying science of the autonomic nervous system activity by leveraging known relationships between cardiac rhythm, heart rate variability, and patient compensatory mechanisms. It is clinically validated to sift through the noise and spot the hidden ECG patterns associated with hemodynamic instability that could indicate emerging signs of shock, and autonomic nervous system compensation.

This technology was developed using supervised machine learning with a dataset labeled by clinicians and validated with data from multiple hospitals. The AHI system uses streaming ECG data from existing patient monitors with sampling frequencies ranging from 120 to 1000 samples per second to continuously produce indications of current and future hemodynamic status for each patient, updated every two minutes. The company provides up to three days’ worth of trended data for each patient that enables clinicians to see a pattern in the patients’ trajectory and make appropriate decisions. The most important aspect of this monitoring is that it uses only a single non-invasive lead of streaming ECG with no manual inputs or special hardware required.

The AHI System is typically deployed as a hospital-wide surveillance tool, largely beneficial in emergency departments, telemetry units, ICUs, and even in the general ward with a patch-based ECG. The data is seamlessly extracted from patient monitors in real-time and securely shipped to a hospital-specific cloud infrastructure where major processing takes place in a matter of seconds. This post-processed data is then delivered to the user base and relayed onto display monitors, phones, computer screens, or any device with an internet browser. The data is presented in a traffic light-like system where green, amber, and red lights denote respective future risks of hemodynamic compromise in a patient. “We store and protect the data for each hospital separately so that we don’t run any risk of data breaches,” explains Jennifer.

Conventional clinical-decision support tool providers utilize multiple types of data points from electronic health records (EHR). Leveraging a wide array of data from EHR to design a machine-learning algorithm that predicts patient health potentially yields incorrect results as the information is inherently delayed and dependent on clinician’s manual inputs. In contrast, Fifth Eye uses real-time data streaming from the patient’s body and provides a continuously monitored system that doesn’t burden clinicians and is easy to use. One such example of an effective and effortless use case is when AHI was used on a young patient with no comorbidities who was brought to the emergency department with shortness of breath and deep vein thrombosis. In this patient, AHI was credited in helping identify signs of instability that were caused by an undiscovered massive pulmonary embolism, which was then treated in a timely manner, likely saving her life.

  • At Fifth Eye, our technology has enabled the application of hemodynamic instability as a new vital sign. We’re empowering clinicians with new information leading to proactive patient re-evaluation rather than costly crisis care


With its advanced patient care platform, Fifth Eye is set to alleviate nursing workload and empower healthcare organizations to get the most out of artificial intelligence in the medical sector. The company also looks forward to extending its analytics to be more specific for particular diagnostic areas by working alongside clinicians and researchers, thereby contributing to improved healthcare.

Top 10 Artificial Intelligence Solutions Companies  - 2022

Company
Fifth Eye

Management
Jennifer Baird, CEO, Fifth Eye

Description
Fifth Eye provides clinicians unique, real-time information on patient status to avoid a crisis via early awareness and intervention of emerging problems. The company's flagship offering, the AHI System, is the first and only FDA-cleared software that leverages an analytic to continuously detect and predict the risk of future episodes of hemodynamic instability 48 minutes ahead of vital signs. Unlike many early warning systems that require manual inputs of vital signs or EHR data, Fifth Eye's AHI system automatically collects data from a continuous ECG signal alone and converts it to hemodynamic status every two minutes. Thus, the AHI System reduces nursing surveillance burden and potentially reduces adverse events by raising awareness of the hemodynamic trajectory of every hospital patient.

Fifth Eye News

Fifth Eye's AHI System™ for Predictive Patient Analytics Now Available in Medical Informatics Corp.'s Sickbay™ Platform

Fifth Eye's AHI System is the only FDA-cleared medical device software of its kind, detecting hemodynamic instability that can signal patient decompensation ahead of vital signs.
ANN ARBOR - Fifth Eye Inc., to announce that their Analytic for Hemodynamic Instability (AHI) is now available to customers using Medical Informatics Corp.'s Sickbay™ Platform, augmenting the platform's patient monitoring and analytics capabilities.
AHI brings expanded information to Sickbay – detecting, trending, and predicting episodes of hemodynamic instability hours1 ahead of vital signs. Data is automatically collected and updated every two minutes, reducing nursing burden while providing access to valuable new information to help clinicians confidently prioritize their time.
"We are excited to extend the power of AHI predictive patient monitoring to more hospitals and patients through the Sickbay™ platform," said Andrew Malcolmson, CEO of Fifth Eye. "AHI is an ideal complement to Sickbay, giving the clinical team deeper insight into patient status and helping avoid a costly patient crash. As clinicians are asked to do more with less, healthcare organizations are recognizing the value of AHI's advanced surveillance capabilities. With 'anytime, anywhere' insight, AHI can increase staff productivity, streamline communications, and empower clinical teams to focus on acute patient care with actionable information."
"An environment of collaboration supports clinical teams in advancing care delivery. We are working alongside healthcare systems and vendors to provide interoperability that serves the hospital to create that environment," said Emma Fauss, CEO of Medical Informatics Corp. "MIC and Fifth Eye are committed to combining best-of-class technologies so clinicians can get ahead of deterioration and manage risk. Fifth Eye's AHI algorithm complements our suite of applications, adding early detection of hemodynamic instability to virtualized care. We look forward to partnering with AHI at scale across the continuum of care."

VitalConnect and Fifth Eye Inc. Announce Agreement to Provide Predictive Patient Analytics that Further Advance Remote Monitoring

Integration adds AHI System (Analytic for Hemodynamic Instability) to award-winning wearable biosensor providing better insights and potential to intervene earlier
SAN JOSE - VitalConnect®, Inc., announced a relationship with Fifth Eye Inc., a provider of intuitive real-time clinical analytics that has been recognized as a "Top Ten Artificial Intelligence Solutions Provider" for multiple years. The VitalConnect end-to-end remote patient monitoring solution already monitors up to 11 measurements in near real-time with customizable alerts, while allowing screening for 21 cardiac arrhythmias, to enable constant and unprecedented insight into patient health. Integrating Fifth Eye's AHI SystemTM, which is the only FDA-cleared medical device software that can detect hemodynamic instability signaling potential deterioration ahead of vital signs, will provide even more comprehensive patient information allowing healthcare professionals to optimize the delivery of care to their patients.
"This is a significant milestone for AHI," said Andrew Malcolmson, CEO of Fifth Eye. "AHI is the only FDA-cleared noninvasive patient monitoring technology of its kind, combining real-time hemodynamic status with a future risk indicator. Adding this unprecedented analytic capability to VitalConnect's robust monitoring parameters results in a wearable solution that is convenient for patients and produces actionable outputs for physicians."
"Incorporating the power of predictive analytics is the future of remote patient monitoring," said VitalConnect CEO Peter Van Haur. "We developed VitalConnect to deliver better healthcare while providing more convenience for the patients and healthcare providers. By integrating AHI, we add a vital new layer of analytic surveillance to provide better insights through detecting potential deterioration significantly sooner than traditional vital signs."